Literature DB >> 30347132

Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease.

Utaroh Motosugi1, Takamichi Murakami2, Jeong Min Lee3, Kathryn J Fowler4, Jay P Heiken5, Claude B Sirlin4.   

Abstract

LEVEL OF EVIDENCE: 5 Technical Efficacy Stage: 3 J. Magn. Reson. Imaging 2018;47:1169-1171.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  hepatobiliary contrast agent; hepatocellular carcinoma; liver; magnetic resonance imaging

Mesh：

Substances：

Year:  2018        PMID： 30347132     DOI： 10.1002/jmri.26515

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN： 1053-1807            Impact factor:   4.813


  6 in total

1.  Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected Liver.

Authors:  Yoshiaki Shimizu; Kuniaki Arai; Taro Yamashita; Tatsuya Yamashita; Tetsuro Shimakami; Kazunori Kawaguchi; Kazuya Kitamura; Yoshio Sakai; Eishiro Mizukoshi; Masao Honda; Azusa Kitao; Kazuto Kozaka; Satoshi Kobayashi; Shuichi Kaneko
Journal:  Liver Cancer       Date:  2020-01-07       Impact factor: 11.740

2.  Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.

Authors:  Shintaro Ichikawa; Utaroh Motosugi; Hiroyuki Morisaka; Kazuto Kozaka; Satoshi Goshima; Tomoaki Ichikawa
Journal:  Magn Reson Med Sci       Date:  2020-02-27       Impact factor: 2.471

3.  Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib.

Authors:  Shun Kaneko; Kaoru Tsuchiya; Yutaka Yasui; Kento Inada; Sakura Kirino; Koji Yamashita; Leona Osawa; Yuka Hayakawa; Shuhei Sekiguchi; Mayu Higuchi; Kenta Takaura; Chiaki Maeyashiki; Nobuharu Tamaki; Takaya Takeguchi; Yuko Takeguchi; Hiroyuki Nakanishi; Jun Itakura; Yuka Takahashi; Yoshiro Himeno; Masayuki Kurosaki; Namiki Izumi
Journal:  JGH Open       Date:  2020-10-16

Review 4.  Diagnosis of Hepatocellular Carcinoma Using Gd-EOB-DTPA MR Imaging.

Authors:  Takamichi Murakami; Keitaro Sofue; Masatoshi Hori
Journal:  Magn Reson Med Sci       Date:  2021-08-21       Impact factor: 2.760

Review 5.  Liver Imaging Reporting and Data System criteria for the diagnosis of hepatocellular carcinoma in clinical practice: A pictorial minireview.

Authors:  Christina Liava; Emmanouil Sinakos; Elissavet Papadopoulou; Lamprini Giannakopoulou; Stamatia Potsi; Anestis Moumtzouoglou; Anthi Chatziioannou; Loukas Stergioulas; Lydia Kalogeropoulou; Ioannis Dedes; Evangelos Akriviadis; Danai Chourmouzi
Journal:  World J Gastroenterol       Date:  2022-08-28       Impact factor: 5.374

6.  Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.

Authors:  Christoph J Zech; Ahmed Ba-Ssalamah; Thomas Berg; Hersh Chandarana; Gar-Yang Chau; Luigi Grazioli; Myeong-Jin Kim; Jeong Min Lee; Elmar M Merkle; Takamichi Murakami; Jens Ricke; Claude B Sirlin; Bin Song; Bachir Taouli; Kengo Yoshimitsu; Dow-Mu Koh
Journal:  Eur Radiol       Date:  2019-08-05       Impact factor: 5.315
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.